Organogenesis Holdings Inc.
ORGONasdaqCIK 1661181HealthcareFiscal year ends Dec 31
Reports and events: 193 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0616:45 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-338321 |
| 2026-08-0616:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-338049 |
| 2026-08-0616:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-338022 |
| 2026-06-1616:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-26-272710 |
| 2026-05-0716:16 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001661181-26-000008 |
| 2026-05-0716:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001661181-26-000007 |
| 2026-04-3016:17 ET | DEF 14A | Proxy statementPeriod 2026-06-15 | 0001193125-26-197357 |
| 2026-02-2616:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-076730 |
| 2026-02-2616:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-076595 |
| 2026-02-2317:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-064270 |
| 2025-12-2916:31 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-335425 |
| 2025-11-0616:28 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269697 |
| 2025-11-0616:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269654 |
| 2025-11-0317:40 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-25-262869 |
| 2025-09-2517:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-217810 |
| 2025-08-0716:16 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105048 |
| 2025-08-0716:11 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105032 |
| 2025-06-2618:24 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-090530 |
| 2025-06-2416:33 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-25-145767 |
| 2025-05-1216:23 ET | DEF 14A | Proxy statementPeriod 2025-06-23 | 0001193125-25-117808 |
| 2025-05-0816:11 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066962 |
| 2025-05-0816:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066930 |
| 2025-04-2917:14 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001193125-25-104050 |
| 2025-03-2717:23 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-065638 |
| 2025-02-2716:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-029137 |
| 2025-02-2716:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-029021 |
| 2025-01-1317:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-004892 |
| 2025-01-0317:18 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-001352 |
| 2024-12-0216:28 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-132248 |
| 2024-11-2216:08 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-130202 |
| 2024-11-1916:05 ET | SC 13D | Ownership report, active investor | 0001193125-24-261721 |
| 2024-11-1420:09 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-259026 |
| 2024-11-1309:28 ET | 8-K | 1.01 Entry into a material agreement; 2.04 Item not in the standard list; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-256699 |
| 2024-11-1216:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125431 |
| 2024-11-1216:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125331 |
| 2024-08-0816:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-094009 |
| 2024-08-0816:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093893 |
| 2024-06-2116:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-165670 |
| 2024-05-0916:25 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-057050 |
| 2024-05-0916:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056885 |
| 2024-04-2916:06 ET | DEF 14A | Proxy statementPeriod 2024-06-20 | 0001193125-24-122223 |
| 2024-04-0317:26 ET | 8-K | 8.01 Other events | 0001193125-24-086129 |
| 2024-02-2916:31 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-023150 |
| 2024-02-2916:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-023059 |
| 2023-11-0916:11 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-062056 |
| 2023-11-0916:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062041 |
| 2023-08-0916:34 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-040670 |
| 2023-08-0916:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-040643 |
| 2023-06-1616:04 ET | 8-K | 5.07 Shareholder vote results | 0001193125-23-168964 |
| 2023-05-1016:47 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-020627 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.